TG Therapeutics Inc

TG Therapeutics Inc Stock

100.22P/E
€8.93BMarket capitalisation
US$0.67Earnings
—Dividend yield

Current price

—
1D
1W
1M
3M
6M
1Y
3Y
Max

Company description

TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on acquiring, developing, and commercializing novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features.

TG Therapeutics Inc is registered in the following country: United States of America (Exchange: USNASD).

Key metrics

Key metrics and master data for the TG Therapeutics Inc stock.

Market capitalisation
€8.93B
P/E
100.22
P/B
16.93
P/S
11.83
P/CF
117.48
Issued shares 151M Units

Return

Here you can see the performance of the TG Therapeutics Inc stock.

PeriodPerfor­mance
1 Week-1.02 %
1 Month+21.67 %
3 Months+36.45 %
6 Months+73.81 %
1 Year+123.84 %
YTD+128.21 %

Dividends

With an (expected) annual dividend of —, the current stock price results in a dividend yield of —.

Dividend type—
(Expected) annual dividend —
Dividend yield —

Splits

The table shows the splits of the TG Therapeutics Inc share.

DateRatio
No data available.

Which ETF contains the TG Therapeutics Inc stock?

The TG Therapeutics Inc stock is contained in a total of 0 ETFs with at least 1%. You can find a list of these ETFs in the following table. With —, TG Therapeutics Inc has the largest weight in .

Name
Weighting
Region
Country
TER
Replication
Volume (£m)

Frequently asked questions

Here you can find all answers to your questions about the TG Therapeutics Inc stock.

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.